Thanks I see it in there now. Will need to read later. Looks more like a reference to the graph from the Forbes article. I couldn’t find that graph among recent JPM published material.
Yes, I did a fly by of my article. Looking at the economic drops that had recently captured.
Based upon the rapid growh of infections in NYC greater area and the issue of NYC residents traveling to other places of the country, if it gets much worse I wouldn’t be surprised we see a quarantine of NYC area of some form in the not too distant future. Asking NYC residents to self-quarantine for 2 weeks when they leave NYC is not going to work and will not be followed. We can’t have them infecting the rest of the country and making the situation worse for the rest of the country.
Enjoy. It’s only 45 minutes long. He plans to have another one on Friday dealing with policy options. This one looks are economic and geopolitical risks.
I think you replied to the wrong poster, SH. I never said that.
xsmithcoog116
(Play through the whistle [ also pass block ])
151
It shouldn’t just be NYC. I really feel that no one should leave their city except for work. What could possibly be more important than that? The fact remains that there are still a number of people in this country who will never be concerned unless it happens to them or a loved one. If we stop spreading it to other cities, surely it should help some.
Every jurisdiction isn’t “shutdown” right now so you can get a hotel outside of those areas. Also, I can see people going to stay with family or friends outside of the city. It doesn’t take that many cases for this to become a huge problem.
True, not bad. That is a better X axis number (deaths per million) to compare against, but it also depends where one is on the curve. We’re still early on the bell curve. So time will tell how we manage it. Also need to compare against others like Germany, Austria, and other central Europ countries as well as SK, Singapore, Taiwan as better practice locations with high density. All listed are leading hot spots. Italy is off the charts.
I wish we would have sooner. Just a few weeks ahead time with China with flights coming in from China and Asia would have helped out British Columbia, Seattle, SF, LA significantly. Doing it sooner with Europe would have helped out NY. Now, we really need to shut down NYs from traveling in the near term.
Sometimes you just want to make a statement and are not actually replying to any particular post. So if you post at the bottom it shows as a reply to post above. A little hitch in the system.
There have been some clinical trials in China and France stating that using Hydroxychloroquine treatment is significantly associated with viral load reduction effect reinforced by Azithromycin. Also, I am working from home with kitchen TV on in background and Doctor Oz had a doctor on saying if this is the only Army we have to send to fight the war today then send the Army. I hope the FDA, CDC and whatever agency is on this and finds out quick.
Personally, I admit guilt to not having read the story and going solely by the headline! A mistake I abhor when others make it! So time to eat some crow!
Summary:
-15 COVID+ in HCQ group, 15 in no drug
-on Day 7 throat swabs were negative in 13/15 HCQ group and 14/15 no drug group.
-One patient in the HCQ group had progression of disease to severe, none in the no drug group
other things they looked at were also similar between the two groups
-Obviously a very small study with a very short window for results, but discouraging results
Results: One patient in HCQ group developed to severe during the treatment. On day 7, COVID-19 nucleic acid of throat swabs was negative in 13 (86.7%) cases in the HCQ group and
14 (93.3%) cases in the control group (P>0.05). The median duration from hospitalization to
virus nucleic acid negative conservation was 4 (1-9) days in HCQ group, which is comparable to
that in the control group [2 (1-4) days, (U = 83.5, P > 0.05)]. The median time for body
temperature normalization in HCQ group was 1 (0-2) after hospitalization, which was also
comparable to that in the control group 1 (0-3). Radiological progression was shown on CT
images in 5 cases (33.3%) of the HCQ group and 7 cases (46.7%) of the control group, and all
patients showed improvement in follow-up examination. Four cases (26.7%) of the HCQ group
and 3 cases (20%) of the control group had transient diarrhea and abnormal liver function (P>
0.05). Conclusions: The prognosis of common COVID-19 patients is good. Larger sample size
study are needed to investigate the effects of HCQ in the treatment of COVID-19. Subsequent
research should determine better endpoint and fully consider the feasibility of experiments such as
sample size.